Name: DMAAR Balance Sheet - Drugs Made In America Acquisition Assets & Debt | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Total Assets, Current Assets, Cash and Equivalents, Total Liabilities, Long-term Debt, Short-term Debt, Shareholders Equity, Working Capital, Book Value Per Share

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

DMAAR - Drugs Made In America Acquisition Corp.

USD | NASDAQ

DMAAR Balance Sheet - Drugs Made In America Acquisition Assets & Debt | Ledgeburg

(in millions of USD)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24
Cash And Short Term Investments
Cash And Equivalents	0.0	0.0	-	-	-	-	-	-
Restricted Cash	-	-	-	-	-	-	-	-
Short Term Investments	-	-	-	-	-	-	-	-
Cash And Short Term Investments	0.0	0.0	-	-	-	-	-	-
Receivables
Accounts Receivable	-	-	-	-	-	-	-	-
Current Assets
Inventory	-	-	-	-	-	-	-	-
Prepaid Expenses	-	0.0	0.0	0.0	0.1	0.0
Non-Current Assets
Property, Plant & Equipment Gross	-	-	-	-	-	-	-	-
Accumulated Depreciation	-	-	-	-	-
Current Liabilities
Accounts Payable	-	-	-	-	-	-	-	-
Short Term Debt	-	-	-	-	-	-
Non-Current Liabilities
Long Term Debt	-	-	-	-	-	-	-	-
Operating Lease Liabilities Non-Current	-	-	-	-	-
Common Equity
Common Stock	0.0	0.0	0.0	0.0	0.0	0.0	-	-
Additional Paid In Capital	-	-	-	-	-	0.0
Supplementary Data
Total Debt	-	-	-	-	-	-	-	-
Net debt	-	-	-	-	-	-

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD)	FY2025	FY2024
Cash And Short Term Investments
Cash And Equivalents	-	-
Restricted Cash	-	-
Short Term Investments	-	-
Cash And Short Term Investments	-	-
Receivables
Accounts Receivable	-	-
Current Assets
Inventory	-	-
Prepaid Expenses	0.0	0.0
Other Current Assets	-	-
Assets Held For Sale	-	-
Total Current Assets
Non-Current Assets
Property, Plant & Equipment Gross	-	-
Accumulated Depreciation	-	-
Property,Plant & Equipment Net	-	-
Long Term Investments	-	-
Current Liabilities
Accounts Payable	-	-
Short Term Debt	-	-
Deferred Revenue Current	-	-
Operating Lease Liabilities Current	-	-
Accrued Expenses
Non-Current Liabilities
Long Term Debt	-	-
Operating Lease Liabilities Non-Current	-	-
Deferred Revenue Non-Current	6.9	-
Deferred Tax Liabilities	-	-
Common Equity
Common Stock	0.0	0.0
Additional Paid In Capital	-	0.0
Retained Earnings	(7.3)	(0.3)
Accumulated Other Comprehensive Income	-	-
Treasury Stock
Supplementary Data
Total Debt	-	-
Net debt	-	-
Working Capital	(0.4)	(0.8)
Book Value	(7.3)	(0.2)
Tangible Book Value

Source: SEC EDGAR company filings. Figures as reported (US GAAP)